Biomaterial-based ocular drug delivery systems are transforming eye care by improving efficacy, reducing treatment burden, and enabling regenerative therapies.
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
- Risk Is the Spine: What The First 100 QMSR Inspections Reveal
- Advancing Autologous Stem Cell Engineering For Diabetes And Vision Loss
- The Hidden Operational Complexities Of Home Infusion
- Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease
ON-DEMAND WEBINARS
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
Through case studies on modified release, poor solubility, and pediatrics, discover how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines for even the most challenging of molecules.
Review the EU Medical Device Regulation (MDR) changes, specifically with respect to integral combination products, and examine the technical documentation packages supporting functionality and content.
Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![West]( "Streamlining Primary Container And Device Selection With Predictive Calculations")
Streamlining Primary Container And Device Selection With Predictive CalculationsExpolore a theoretical approach to complement experimental approaches to more quickly select a packaging and delivery system for your drug product.
-
![GettyImages-1279969622-self-injector-injection]( "Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality")
Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product QualityStrengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.
-
![GettyImages-1027752634]( "Selecting An Alternative Coating Technology To Silicone Oil For Prefillable Syringes")
Selecting An Alternative Coating Technology To Silicone Oil For Prefillable SyringesThe challenges of silicone-oil lubrication and the growing trend for more viscous, protein-based drugs are now leading pharma and biotech companies to investigate alternative solutions.
-
![West1]( "Reliable Components For The Lifecycle Of Your Injectable Drug Product")
Reliable Components For The Lifecycle Of Your Injectable Drug ProductAs drug products increase in complexity, become more specialized, and trend towards self-administration, it is more important than ever to have a reliable drug closure system.
-
![RA-Device-V6-March-16_copy]( "Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization")
Insights Into Drug Delivery Device Manufacturing From Development Through CommercializationBiologics and other targeted therapy techniques are creating opportunities for innovative device solutions that meet the needs of specific patient groups. As these therapies often require low annual volumes, the associated device manufacturing strategy must also fit commercial expectations, even at those volumes.
-
![06 West]( "Your Approach To USP <382> For Your Drug Product Packaging")
Your Approach To USP <382> For Your Drug Product PackagingThe USP requirements for elastomeric components of container closure systems used for parenteral products are changing. Explore the implications for vial, syringe, and cartridge container closure systems.
-
![GettyImages-1371707479-lab-mask-team-partnership]( "Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products")
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug ProductsDrug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
![West1]( "Early Decisions To De-Risk The Transition To Combination Products")
Early Decisions To De-Risk The Transition To Combination ProductsThe injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?
-
![Syringes GettyImages-171324030]( "Key Considerations When Filling Dual Chamber Syringes")
Key Considerations When Filling Dual Chamber SyringesDual-chamber syringes (DCSs) are in high demand across the pharmaceutical and hospital industries. Learn about the challenges of the DCS filling manufacturing market and how to overcome them.
-
![image1]( "NovaPure Stoppers - The Right Choice For Oncology Drugs")
NovaPure Stoppers - The Right Choice For Oncology DrugsVial containment systems with NovaPure® elastomer stoppers offer substantial performance benefits with their enhanced dimension control, reduced particle levels, inspection of every stopper, and use of FluroTec® film. Explore the performance of the film and why NovaPure stoppers should be the choice for sensitive drug products.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing")
Procuring Packaging And Delivery Systems: Single Versus Dual SourcingIn this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
